Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 7/20 | 0.46 |
| ▸ | NMUR1 | Q9HB89 | 7/20 | 0.46 |
| ▸ | EPHA2 | P29317 | 4/20 | 0.42 |
| ▸ | NPY4R | P50391 | 4/20 | 0.42 |
| ▸ | NPY1R | P25929 | 3/20 | 0.42 |
| ▸ | NPY2R | P49146 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9632114 | 0.83 | NMUR2 (0.46) | NMUR2NMUR1EPHA2NPY4RNPY1R | |
| SCHEMBL29510980 | 0.82 | NPY4R (0.55) | NMUR2NMUR1EPHA2NPY4RNPY1R | |
| SCHEMBL9629967 | 0.78 | NPY4R (0.44) | NMUR2NMUR1EPHA2NPY4RNPY1R | |
| SCHEMBL29813882 | 0.75 | OPRK1 (0.44) | NMUR2NMUR1NPY4RNPY1RNPY2R | |
| SCHEMBL22288702 | 0.74 | KISS1R (0.57) | — | |
| SCHEMBL22288705 | 0.74 | KISS1R (0.57) | — | |
| SCHEMBL34464914 | 0.74 | GNRHR (0.60) | — | |
| SCHEMBL10586963 | 0.74 | NMUR2 (0.57) | NMUR2NMUR1EPHA2NPY4RNPY1R | |
| SCHEMBL9630914 | 0.73 | NMUR2 (0.53) | NMUR2NMUR1NPY4RNPY1RNPY2R | |
| Hydrochloric Acid SCHEMBL11665303 | 0.73 | NMUR2 (0.58) | NMUR2NMUR1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413209-A1 | LHRH analogs | TAP Pharmaceuticals Inc. (US) | 1991-02-20 | — | — | EP | disclosed |
| EP-0328090-A2 | LHRH analogs | ABBOTT LABORATORIES (US) | 1989-08-16 | — | — | EP | disclosed |